Glaxosmithkline Vaccine
-
Sanofi’s COVID-19 vaccine sees up to 100% efficacy in latest trialThe robust immune response results enable Sanofi and GlaxoSmithKline to move to a late-stage study, the French drugmaker said.WorldMay 17, 2021
-
Drugmakers partner to develop COVID-19 vaccines aimed at new variantsThe announcement comes as public health officials around the world raise concerns about new virus variants that are more contagious or resistant to existing vaccines.WorldFeb 3, 2021
-
Two drugmakers say their coronavirus vaccine won’t be ready until late 2021"The results of the study are not as we hoped," Roger Connor, president of GSK Vaccines, said in a statement.WorldDec 11, 2020
![]()
